Du and colleagues showed that miR-223 may enhance the cell proliferation, migration, invasion, and EMT of breast cancer cells through the Hippo/Yes-associated protein 1 (Yap1) signaling pathway [145]. This evidence concerns the gene YAP1 and breast cancer.